{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:10:44Z","timestamp":1788408644809,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Italian Ministry of Health","award":["Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Fondo Ricerca Corrente 2016 850\/01"],"award-info":[{"award-number":["Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Fondo Ricerca Corrente 2016 850\/01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s40272-016-0185-1","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:18:44Z","timestamp":1469524724000},"page":"347-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis"],"prefix":"10.1007","volume":"18","author":[{"given":"Susanna","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Osnaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Ghiglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"key":"185_CR1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1755-3768.2008.01347.x","volume":"87","author":"S Kumar","year":"2009","unstructured":"Kumar S. Vernal keratoconjunctivitis: a major review. Acta Ophthalmol. 2009;87:133\u201347.","journal-title":"Acta Ophthalmol"},{"key":"185_CR2","first-page":"436","volume":"7","author":"S Bonini","year":"2007","unstructured":"Bonini S, Sacchetti M, Mantelli F, Lambiase A. Clinical grading of vernal keratoconjunctivitis. Clin Immunol. 2007;7:436\u201341.","journal-title":"Clin Immunol"},{"key":"185_CR3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0420.2005.00622.x","volume":"84","author":"A Leonardi","year":"2006","unstructured":"Leonardi A, Busca F, Motterle L. Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. Acta Ophtalmol Scand. 2006;84:406\u201310.","journal-title":"Acta Ophtalmol Scand"},{"key":"185_CR4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","volume":"107","author":"S Bonini","year":"2000","unstructured":"Bonini S, Bonini S, Lambiase A, Marchi S, Pasqualetti P, Zuccaro O, Rama P, Magrini L, Juhas T, Bucci MG. Vernal keratoconjuntivitis revisited. A case series of 195 patients with long-term follow up. Ophtalmology. 2000;107:1157\u201363.","journal-title":"Ophtalmology."},{"key":"185_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lfs.2015.01.040","volume":"128","author":"L Pattnaik","year":"2015","unstructured":"Pattnaik L, Acharya L. A comprehensive review on vernal keratoconjuntivitis with emphasis on proteomics. Life Sci. 2015;128:47\u201354.","journal-title":"Life Sci"},{"key":"185_CR6","first-page":"25","volume":"21","author":"P Kosrirukvongs","year":"2003","unstructured":"Kosrirukvongs P, Vichyanond P, Wongsawad W. Vernal keratoconjunctivitis in Thailand. Asian Pac J Allergy Immunol. 2003;21:25\u201330.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"185_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/bjophthalmol-2011-301376","volume":"97","author":"S Smedt De","year":"2013","unstructured":"De Smedt S, Wildner G, Kestelyn P. Vernal keratoconjunctivitis: an update. Br J Ophtalmol. 2013;97:9\u201314.","journal-title":"Br J Ophtalmol"},{"key":"185_CR8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.eye.6700675","volume":"18","author":"S Bonini","year":"2004","unstructured":"Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye. 2004;18:345\u201351.","journal-title":"Eye"},{"key":"185_CR9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00003226-200110000-00014","volume":"20","author":"T Miyoshi","year":"2001","unstructured":"Miyoshi T, Fukagawa K, Shimmura S, Fujishima H, Takano Y, Takamura E, Tsubota K, Saito H, Oguchi Y. Interleukin 8 concentrations in conjunctival epithelium brush cytology samples correlates with neutrophil, eosinophil infiltration, and corneal damage. Cornea. 2001;20:743\u20137.","journal-title":"Cornea"},{"key":"185_CR10","first-page":"1242","volume":"17","author":"AM Zicari","year":"2013","unstructured":"Zicari AM, Nebbioso M, Zicari A, Mari E, Celani C, Occasi F, Tubili F, Duse M. Serum levels of IL-17 in patients with vernal keratoconjunctivitis: a preliminary report. Eur Rev Med Pharmacol Sci. 2013;17:1242\u20134.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"185_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/OPTH.S38732","volume":"7","author":"PJ Gomes","year":"2013","unstructured":"Gomes PJ, Ousler GW, Welch DL, Smith LM, Coderre J, Abelson MB. Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy. Clin Ophthalmol. 2013;7:157\u201365.","journal-title":"Clin Ophthalmol"},{"key":"185_CR12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0002-9394(99)00295-0","volume":"129","author":"A Leonardi","year":"2000","unstructured":"Leonardi A, Borghesan F, Faggian D, Depaoli M, Secchi AG, Plebani M. Tear and serum soluble leukocyte. Am J Ophtalmol. 2000;129:151\u20138.","journal-title":"Am J Ophtalmol."},{"key":"185_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/pai.12142","volume":"25","author":"AM Zicari","year":"2014","unstructured":"Zicari AM, Zicari A, Nebbioso M, Mari E, Celani C, Lollobrigida V, Cesoni Marcelli A, Occasi F, Duse M. High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis. Pediatr Allergy Immunol. 2014;25:57\u201363.","journal-title":"Pediatr Allergy Immunol"},{"key":"185_CR14","first-page":"1419","volume":"17","author":"AM Zicari","year":"2013","unstructured":"Zicari AM, Nebbioso M, Lollobrigida V, Bardanzellu F, Celani C, Occasi F, Cesoni Marcelli A, Duse M. Vernal keratoconjunctivitis: atopy and autoimmunity. Eur Rev Med Pharmacol Sci. 2013;17:1419\u201323.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"185_CR15","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0091-6749(96)70103-3","volume":"98","author":"DP Metz","year":"1996","unstructured":"Metz DP, Bacon AS, Holgate ST. Phenotypic characterisation of T-cells infiltrating the conjunctiva in chronic allergic eye disease. J Allergy Clin Immunol. 1996;98:686\u201396.","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl. 1","key":"185_CR16","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/01.ico.0000136671.50777.fe","volume":"23","author":"D Miyazaki","year":"2004","unstructured":"Miyazaki D, Nakamura T, Komatsu N. Roles of chemokines in ocular allergy and possible therapeutic strategies. Cornea. 2004;23(Suppl. 1):S48\u201354.","journal-title":"Cornea"},{"key":"185_CR17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archopht.119.3.338","volume":"119","author":"K Tabbara","year":"2001","unstructured":"Tabbara K. Tear tryptase in vernal keratoconjunctivitis. Arch Ophtalmol. 2001;119:338\u201342.","journal-title":"Arch Ophtalmol"},{"key":"185_CR18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/eye.1989.63","volume":"3","author":"SJ Tuft","year":"1989","unstructured":"Tuft SJ, Dart JKG, Kemeny M. Limbal vernal keratoconjunctivitis: clinical characteristics and immunoglobilin E expression compared with palpebral vernal. Eye. 1989;3:420\u20137.","journal-title":"Eye"},{"key":"185_CR19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/pai.12197","volume":"25","author":"P Vichyanond","year":"2014","unstructured":"Vichyanond P, Pacharn P, Pleyer U, Leonardi A. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes. Pediatr Allergy Immunol. 2014;25:314\u201322.","journal-title":"Pediatr Allergy Immunol"},{"key":"185_CR20","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.iop.0000246609.39499.da","volume":"22","author":"RY Griffin","year":"2006","unstructured":"Griffin RY, Sarici A, Unal L. Acquired ptosis secondary to vernal conjunctivitis in young adults. Ophthalmic Past Reconstr Surg. 2006;22:438\u201340.","journal-title":"Ophthalmic Past Reconstr Surg"},{"key":"185_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1442-9071.2011.02693.x","volume":"39","author":"Q Le","year":"2011","unstructured":"Le Q, Hong J, Zhu W, Sun X, Xu J. In vivo laser scanning confocal microscopy of vernal keratoconjunctivitis. Clin Exp Ophtalmol. 2011;39:53\u201360.","journal-title":"Clin Exp Ophtalmol"},{"key":"185_CR22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11882-010-0101-7","volume":"10","author":"S Kumar","year":"2010","unstructured":"Kumar S, Gupta N, Vivian AJ. Modern approach to managing vernal keratoconjunctivitis. Curr Allergy Asthma Rep. 2010;10:155\u201362.","journal-title":"Curr Allergy Asthma Rep"},{"key":"185_CR23","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2165\/00003495-200262110-00004","volume":"62","author":"L Bielory","year":"2002","unstructured":"Bielory L. Ocular allergy guidelines: a practical treatment algorithm. Drugs. 2002;62:1611\u201334.","journal-title":"Drugs"},{"key":"185_CR24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archopht.1997.01100150036004","volume":"115","author":"CN Soparkar","year":"1997","unstructured":"Soparkar CN, Wilhelmus KR, Koch DD, Wallace GW, Jones DB. Acute and chronic conjunctivitis due to over-the-counter ophtalmic decongestants. Arch Ophtalmol. 1997;115:34\u20138.","journal-title":"Arch Ophtalmol"},{"key":"185_CR25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00130832-200210000-00009","volume":"2","author":"MK Church","year":"2002","unstructured":"Church MK, McGill JI. Human ocular mast cells. Curr Opin Allergy Clin Immunol. 2002;2:419\u201322.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"185_CR26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40123-013-0019-y","volume":"2","author":"A Leonardi","year":"2013","unstructured":"Leonardi A. Management of vernal keratoconjunctivitis. Ophthalmol Ther. 2013;2:73\u201388.","journal-title":"Ophthalmol Ther"},{"key":"185_CR27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bjo.81.1.23","volume":"81","author":"A Leonardi","year":"1997","unstructured":"Leonardi A, Borghesan F, Avarello A, Plebani M, Secchi AG. Effect of lodoxamide and disodium cromoglicateon tear eosinophil cationic protein in vernal keratoconjunctivitis. Br J Ophthalmol. 1997;81:23\u20136.","journal-title":"Br J Ophthalmol"},{"key":"185_CR28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.all.0000183113.63311.11","volume":"5","author":"L Bielory","year":"2005","unstructured":"Bielory L, Ghafoor S. Histamine receptors and the conjunctiva. Curr Opin Allergy Clin Immunol. 2005;5:437\u201340.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"185_CR29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000069459","volume":"115","author":"LK Wiemer","year":"1998","unstructured":"Wiemer LK, Gamache DA, Yanni JM. Histamine-stimulated cytokine secretion from human conjunctival epithelial cells: inhibition by the histamine H1 antagonist emedastine. Int Arch Allergy Immunol. 1998;115:288\u201393.","journal-title":"Int Arch Allergy Immunol"},{"key":"185_CR30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1590\/S0004-27492006000600013","volume":"69","author":"WT Hida","year":"2006","unstructured":"Hida WT, Nogueira DC, Schaefer A, Dantas PE, Dantas MC. Comparative study between 0.025\u00a0% ketotifen fumarate and 0.1\u00a0% olopatadine hydrochloride in the treatment of vernal keratoconjunctivitis. Arq Bras Ophtalmol. 2006;69:851\u20136.","journal-title":"Arq Bras Ophtalmol"},{"key":"185_CR31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10792-004-1818-x","volume":"25","author":"JI McGill","year":"2004","unstructured":"McGill JI. A review of the use of olopatadine in allergic conjunctivitis. Int Ophtalmol. 2004;25:171\u20139.","journal-title":"Int Ophtalmol"},{"key":"185_CR32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00055735-200012000-00016","volume":"11","author":"MC Carnahan","year":"2000","unstructured":"Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophtalmol. 2000;11:478\u201383.","journal-title":"Curr Opin Ophtalmol"},{"key":"185_CR33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","volume":"25","author":"CN McGhee","year":"2002","unstructured":"McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf. 2002;25:33\u201355.","journal-title":"Drug Saf"},{"key":"185_CR34","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2147\/OPTH.S32936","volume":"6","author":"M Ang","year":"2012","unstructured":"Ang M, Ti SE, Loh R, Farzavandi S, Zhang R, Tan D, Chan C. Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis. Clin Ophtalmol. 2012;6:1253\u20138.","journal-title":"Clin Ophtalmol"},{"key":"185_CR35","first-page":"177","volume":"45","author":"A Sharma","year":"1997","unstructured":"Sharma A, Gupta R, Ram J, Gupta A. Topical ketorolac 0.5\u00a0% solution for the treatment of vernal conjunctivitis. Indian J Ophtalmol. 1997;45:177\u201380.","journal-title":"Indian J Ophtalmol"},{"key":"185_CR36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00417-002-0612-6","volume":"241","author":"G D\u2019Angelo","year":"2003","unstructured":"D\u2019Angelo G, Lambiase A, Cortes M, Sgrulletta R, Pasqualetti R, Lamagna A, Bonini S. Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophtalmol. 2003;241:192\u20135.","journal-title":"Graefes Arch Clin Exp Ophtalmol"},{"key":"185_CR37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1755-3768.1991.tb02000.x","volume":"69","author":"S Gupta","year":"1991","unstructured":"Gupta S, Khurana AK, Ahluvalia BK, Gipta NC. Topical indomethacin for vernal keratoconjunctivitis. Acta Ophtalmol (Copenh.). 1991;69:95\u20138.","journal-title":"Acta Ophtalmol (Copenh.)"},{"key":"185_CR38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000080937","volume":"218","author":"E Bertelmann","year":"2004","unstructured":"Bertelmann E, Pleyer U. Immunomodulatory therapy in ophthalmology. Is there a place for topical application? Ophthalmologica. 2004;218:359\u201367.","journal-title":"Ophthalmologica"},{"issue":"Suppl. 1","key":"185_CR39","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/ICO.0b013e31812f6970","volume":"26","author":"A Fukushima","year":"2007","unstructured":"Fukushima A. Roles of T-cells in the development of allergic conjunctival disease. Cornea. 2007;26(Suppl. 1):S36\u201340.","journal-title":"Cornea"},{"key":"185_CR40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.17219\/acem\/37145","volume":"23","author":"U Keklikci","year":"2014","unstructured":"Keklikci U, Dursun B, Cingu AK. Topical cyclosporin A 0.05\u00a0% eyedrops in the treatment of vernal keratoconjunctivitis. Randomized placebo-controlled trial. Adv Clin Exp Med. 2014;23:455\u201361.","journal-title":"Adv Clin Exp Med"},{"key":"185_CR41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","volume":"89","author":"N Pucci","year":"2002","unstructured":"Pucci N, Novembre E, Cianferoni A, Lombardi E, Bernardini R, Caputo R, Campa L, Vierucci A. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Ann Allergy Asthma Immunol. 2002;89:298\u2013303.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"185_CR42","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3129\/i06-061","volume":"41","author":"A Kilic","year":"2006","unstructured":"Kilic A, Gurler B. Topical 2\u00a0% cyclopsporine A in preservative-free artificial tears for treatmentof vernal keratoconjunctivitis. Can J Opthalmol. 2006;41:693\u20138.","journal-title":"Can J Opthalmol"},{"key":"185_CR43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1399-3038.2006.00427.x","volume":"17","author":"L Spadavecchia","year":"2006","unstructured":"Spadavecchia L, Fanelli P, Tesse R, Brunetti L, Cardinale F, Bellizzi M, Rizzo G, Procoli U, Bellizzi G, Armenio L. Efficacy of 1.25\u00a0% and 1\u00a0% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood. Pediatr Allergy Immunol. 2006;17:527\u201332.","journal-title":"Pediatr Allergy Immunol"},{"key":"185_CR44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2008.0103","volume":"25","author":"N Ebihara","year":"2009","unstructured":"Ebihara N, Ohashi Y, Uchio E, Okamoto S, Kumagai N, Shoji J, Takamura E, Nakagawa Y, Nanba K, Fukushima A, Fujishima H. A large prospective observational study of novel cyclosporine 0.1\u00a0% aqueous ophtalmic solution in the treatment of severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2009;25:365\u201372.","journal-title":"J Ocul Pharmacol Ther"},{"key":"185_CR45","first-page":"396987","volume":"2014","author":"MM Wu","year":"2014","unstructured":"Wu MM, Yau GS, Lee JW, Wong AL, Tam VT, Yuen CY. Retrospective review on the use of topical cyclosporin a 0.05\u00a0% for paediatric allergic conjunctivitis in Hong Kong Chinese. Scient World J. 2014;2014:396987.","journal-title":"Scient World J"},{"key":"185_CR46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/bjophthalmol-2011-300415","volume":"96","author":"S Smelt De","year":"2012","unstructured":"De Smelt S, Nkurikiye J, Fonteyne Y, Tuft S, De Bacquer D, Gilbert C, Kestelyn P. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, central Africa: a prospective, randomised, double-masked, controlled clinical trial. Br J Ophthalmol. 2012;96:323\u20138.","journal-title":"Br J Ophthalmol"},{"key":"185_CR47","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11882-013-0345-0","volume":"13","author":"P Vichyanond","year":"2013","unstructured":"Vichyanond P, Kosrirukvongs P. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis. Curr Allergy Asthma Rep. 2013;13:308\u201314.","journal-title":"Curr Allergy Asthma Rep"},{"key":"185_CR48","doi-asserted-by":"crossref","unstructured":"Ohashi Y, Ebihara N, Fujishima H, Fukushima A, Kumagai N, Nakagawa Y, Namba K, Okamoto S, Shoji J, Takamura E, Hayashi K. A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1\u00a0% in severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2010;26:165\u2013174.","DOI":"10.1089\/jop.2009.0087"},{"key":"185_CR49","unstructured":"Labcharoenwongs P, Jirapongsananuruk O, Visitsunthorn N, Kosrirukvongs P, Saengin P, Vichyanond P. A double-asked comparison of 0.1\u00a0% tacrolimus ointment and 2\u00a0% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children. Asian Pac J Allergy Immunol. 2012;30:177\u2013184."},{"key":"185_CR50","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/pai.12360","volume":"26","author":"N Pucci","year":"2015","unstructured":"Pucci N, Caputo R, di Grande L, de Libero C, Mori F, Barni S, di Simone L, Calvani A, Rusconi F, Novembre E. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: a randomized, comparative, double-blind crossover study. Pediatr Allergy Immunol. 2015;26:256\u201361.","journal-title":"Pediatr Allergy Immunol"},{"key":"185_CR51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jaapos.2012.12.153","volume":"17","author":"TA Klerk de","year":"2013","unstructured":"de Klerk TA, Sharma V, Arkwright PD, Biswas S. Severe vernal keratoconjunctivitis successfully treated with subcutaneous omalizumab. J AAPOS. 2013;17:305\u20136.","journal-title":"J AAPOS"},{"key":"185_CR52","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/pai.12197","volume":"25","author":"P Vichyanond","year":"2014","unstructured":"Vichyanond P, Pacharn P, Pleyer U, Leonardi A. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis. Pediatr Allergy Immunol. 2014;25:314\u201322.","journal-title":"Pediatr Allergy Immunol"},{"key":"185_CR53","unstructured":"Reddy JC, Basu S, Saboo US, Murthy SI, Vaddavalli PK, Sangwan VS. Management, clinical outcomes, and complications of shield ulcers in vernal keratoconjunctivitis. Am J Ophtalmology. 2013;155:550\u2013559, e1."},{"key":"185_CR54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200315937","volume":"111","author":"J Sohn","year":"2003","unstructured":"Sohn J, Kim TI, Yoon YH, Kim JY, Kim SY. Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. J Clin Invest. 2003;111:121\u20138.","journal-title":"J Clin Invest"},{"key":"185_CR55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0420.1999.tb01171.x","volume":"228","author":"JM Yanni","year":"1999","unstructured":"Yanni JM, Sharif NA, Gamache DA, Miller ST, Weimer LK, Spellman JM. A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs. Acta Ophthalmol Scand Suppl. 1999;228:33\u20137.","journal-title":"Acta Ophthalmol Scand Suppl."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-016-0185-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-016-0185-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-016-0185-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T18:10:16Z","timestamp":1568225416000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-016-0185-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1007\/s40272-016-0185-1","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]}}}